← FDA Drug Approvals (Drugs@FDA)
NITROGLYCERIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2021-05-03
Drug application
- FDA Application #
ANDA209779- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NITROGLYCERIN
- Generic name
- NITROGLYCERIN
- Active ingredients
- NITROGLYCERIN
- Dosage form
- TABLET
- Route
- SUBLINGUAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- Advagen Pharma Ltd
- First approval
- 2021-05-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown